Loading…
Tarsons Products (TARSONS)₹318.55−0.53%Medical Equipment & Supplies
In the Jun 2026 quarter (consolidated), Tarsons Products reported sales of ₹110 Cr, up 20.5% from Jun 2025, and net profit of −₹1.45 Cr, down 181.0% year on year. For the year to Mar 2026, sales were ₹422 Cr and net profit ₹14.05 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 61.60 | 105 | 84.50 | 98.96 | 95.40 | 112 | 91.13 | 102 | 108 | 121 | 110 |
| Expenses | 38.89 | 75.50 | 66.07 | 73.87 | 66.03 | 75.59 | 66.65 | 74.83 | 76.41 | 86.68 | 84.18 |
| Operating Profit | 22.94 | 30.31 | 18.81 | 25.38 | 29.71 | 37.11 | 24.75 | 27.52 | 31.61 | 34.33 | 26.05 |
| OPM % | 37.1% | 28.6% | 22.2% | 25.6% | 31.0% | 32.9% | 27.1% | 26.9% | 29.2% | 28.4% | 23.6% |
| Other Income | 3.25 | 3.39 | 2.92 | 8.45 | 0.86 | 3.79 | 3.35 | 5.81 | 7.09 | 6.84 | 6.00 |
| Interest | 2.52 | 4.26 | 4.33 | 4.85 | 5.04 | 5.21 | 5.08 | 5.19 | 6.06 | 6.26 | 6.28 |
| Depreciation | 10.03 | 12.30 | 11.01 | 14.00 | 17.36 | 19.98 | 19.89 | 22.42 | 24.99 | 28.99 | 26.95 |
| Profit before tax | 13.53 | 16.99 | 6.31 | 14.83 | 8.03 | 15.52 | 3.02 | 5.58 | 7.48 | 5.76 | −1.31 |
| Tax % | 26.6% | 39.4% | 36.3% | 30.7% | 34.6% | 34.4% | 41.2% | 40.5% | 32.9% | 27.5% | 9.1% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −0.99 | 0.00 | 0.00 |
| Net Profit | 9.96 | 10.36 | 4.03 | 10.32 | 5.28 | 10.24 | 1.79 | 3.33 | 5.06 | 4.19 | −1.45 |
| EPS (Rs) | 1.86 | 1.93 | 0.75 | 1.92 | 1.00 | 1.91 | 0.32 | 0.61 | 0.96 | 0.78 | −0.26 |
| Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|
| Sales | 228 | 300 | 295 | 391 | 422 | 440 |
| Expenses | 125 | 148 | 196 | 282 | 305 | 322 |
| Operating Profit | 103 | 153 | 100 | 111 | 118 | 120 |
| OPM % | 45.0% | 51.1% | 34.0% | 28.0% | 28.0% | 27.2% |
| Other Income | 5.01 | 8.02 | 11.02 | 16.05 | 23.05 | 25.74 |
| Interest | 3.01 | 4.01 | 10.01 | 20.01 | 23.02 | 23.79 |
| Depreciation | 13.95 | 21.94 | 39.89 | 61.84 | 96.71 | 103 |
| Profit before tax | 91.84 | 135 | 60.81 | 44.86 | 21.96 | 17.51 |
| Tax % | 24.9% | 25.0% | 29.9% | 33.9% | 34.9% | — |
| Exceptional items | 0.07 | 0.02 | −0.04 | 0.23 | −0.73 | −0.99 |
| Net Profit | 69.25 | 101 | 43.15 | 30.10 | 14.05 | 11.13 |
| EPS (Rs) | 3,583.52 | 18.91 | 8.00 | 5.59 | 2.68 | 2.09 |
| Dividend payout % | 0.0% | 0.0% | 24.9% | 0.0% | 0.0% | — |
| Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 0.20 | 11.03 | 11.03 | 11.03 | 11.02 |
| Reserves | 243 | 478 | 600 | 618 | 622 |
| Borrowings | 34.12 | 22.06 | 270 | 340 | 394 |
| Other Liabilities | 18.09 | 33.16 | 90.25 | 110 | 157 |
| Total Liabilities | 296 | 543 | 971 | 1,078 | 1,183 |
| Fixed Assets | 120 | 188 | 335 | 534 | 730 |
| CWIP | 22.05 | 32.08 | 267 | 234 | 160 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 153 | 323 | 369 | 311 | 295 |
| Inventories | 46.97 | 81.97 | 129 | 126 | 130 |
| Trade receivables | 46.89 | 64.82 | 77.84 | 79.86 | 84.75 |
| Cash & equivalents | 2.99 | 85.86 | 22.97 | 25.97 | 24.99 |
| Total Assets | 296 | 543 | 971 | 1,078 | 1,183 |
| Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Cash from operating activity | 67.90 | 82.86 | 103 | 114 | 118 |
| Cash from investing activity | −64.11 | −138 | −286 | −145 | −130 |
| Cash from financing activity | −26.99 | 130 | 136 | 38.99 | 8.99 |
| Net cash flow | −22.99 | 75.01 | −47.03 | 8.01 | −2.99 |
| Capex | 61.79 | 132 | 183 | 152 | 126 |
| Free cash flow | 6.01 | −48.03 | −81.07 | −37.01 | −7.01 |
| CFO / OP % | 89.0% | 77.0% | 121.0% | 117.0% | 107.0% |
| Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor days | 76 | 80 | 97 | 75 | 75 |
| Inventory days | 276 | 477 | 571 | 354 | 340 |
| Days payable | 34 | 74 | 64 | 43 | 52 |
| Cash conversion cycle | 317 | 482 | 602 | 385 | 361 |
| Working capital days | 107 | 149 | −2 | 37 | −21 |
| ROCE % | — | 35.0% | — | 7.0% | 5.0% |
For the Jun 2026 quarter, Tarsons Products reported sales of ₹110 Cr, up 20.5% year on year and net profit of −₹1.45 Cr, down 181.0% year on year. The operating margin was 23.6%.
Tarsons Products' sales for the year to Mar 2026 were ₹422 Cr; over the last twelve months they were ₹440 Cr.
Net profit for the year to Mar 2026 was ₹14.05 Cr, and ₹11.13 Cr over the last twelve months. Earnings per share over the same trailing period were ₹2.09.
Tarsons Products reported borrowings of ₹394 Cr at Mar 2026, against cash and equivalents of ₹24.99 Cr.
Cash from operations was ₹118 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹7.01 Cr.